Company Filing History:
Years Active: 1992-1993
Title: Dagobert Schafer: Innovator in Ultrasonic Technology
Introduction
Dagobert Schafer is a notable inventor based in Bretten, Germany. He has made significant contributions to the field of ultrasonic technology, particularly in medical applications. With a total of 3 patents to his name, Schafer's work has advanced the methods used in treatments such as lithotripsy.
Latest Patents
Schafer's latest patents include an ultrasonic shock-wave transducer and a piezoelectric transducer. The ultrasonic shock-wave transducer is designed for use in lithotripsy and hypothermia treatments. It generates ultrasonic shock waves that are focused onto specific points to effectively target and destroy unwanted tissue or concretions. The design allows for the energy to be concentrated along a curved line in three dimensions, enhancing its effectiveness.
The piezoelectric transducer, on the other hand, is aimed at generating focused ultrasonic shock waves specifically for lithotripsy. This device emits ultrasonic shock waves in a pulsed form, which can be transmitted through a coupling medium to the patient's body. It consists of multiple piezoelectric elements arranged in a mosaic pattern, ensuring minimal reflection at the acoustic termination. An intermediate medium is also utilized to optimize the transmission of sound waves.
Career Highlights
Dagobert Schafer is currently associated with Richard Wolf GmbH, a company known for its innovative medical technology solutions. His work at the company has been pivotal in developing advanced ultrasonic devices that improve patient outcomes in various medical treatments.
Collaborations
Schafer has collaborated with notable colleagues such as Peter Jaggy and Werner Krauss. Their combined expertise has contributed to the successful development of innovative technologies in the field of ultrasonic applications.
Conclusion
Dagobert Schafer's contributions to ultrasonic technology have made a significant impact in the medical field. His innovative patents and collaborations continue to pave the way for advancements in treatment methodologies.